GAIN THERAPEUTICS INC

Ticker: GANX CUSIP: 36269B105 Class: COM

DME Capital Management, LP's Holding History (CIK: 0001489933)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 566,130 Value ($000) $1,823 Avg Close $2.67 Range $1.66 - $4.34
Q3 2025
Shares 566,130 Value ($000) $1,002 Avg Close $1.69 Range $1.41 - $2.12
Q2 2025
Shares 566,130 Value ($000) $1,019 Avg Close $1.85 Range $1.48 - $2.27
Q1 2025
Shares 566,130 Value ($000) $1,081 Avg Close $2.22 Range $1.54 - $2.81
Q4 2024
Shares 566,130 Value ($000) $1,223 Avg Close $2.01 Range $1.50 - $3.19
Q3 2024
Shares 566,130 Value ($000) $1,008 Avg Close $1.26 Range $0.89 - $2.00
Q2 2024
Shares 566,130 Value ($000) $725 Avg Close $2.60 Range $1.20 - $4.04
Q1 2024
Shares 566,130 Value ($000) $2,134 Avg Close $4.15 Range $3.17 - $5.33